Matching articles for "Guaifenesin"
Hydrocodone/Chlorpheniramine (Vituz)
The Medical Letter on Drugs and Therapeutics • November 25, 2013; (Issue 1430)
An oral solution (Vituz – Hawthorne) containing two old
drugs, the centrally-acting opioid hydrocodone bitartrate
and the first-generation H1-antihistamine chlorpheniramine
maleate, has been approved by...
An oral solution (Vituz – Hawthorne) containing two old
drugs, the centrally-acting opioid hydrocodone bitartrate
and the first-generation H1-antihistamine chlorpheniramine
maleate, has been approved by the FDA
for relief of cough and [other] symptoms associated
with upper respiratory allergies or a common cold in
adults. Several extended-release products containing
hydrocodone and chlorpheniramine are available as
capsules and suspensions and have been used for
years for similar indications. Vituz is classified as a
schedule III controlled substance, but the FDA has
asked the DEA to reclassify hydrocodone products as
schedule II.
In Brief: Mucinex
The Medical Letter on Drugs and Therapeutics • February 14, 2005; (Issue 1202)
Patients may be asking health care providers about the safety and effectiveness of Mucinex (Adams), which is being heavily advertised on television and elsewhere for treatment of respiratory congestion. These...
Patients may be asking health care providers about the safety and effectiveness of Mucinex (Adams), which is being heavily advertised on television and elsewhere for treatment of respiratory congestion. These ads suggest that Mucinex is a new drug, when actually it is an extended-release formulation of guaifenesin, an old expectorant. Guaifenesin increases the volume of secretions in the respiratory tract, which facilitates removal of viscous mucus by coughing. Medical Letter consultants have not been impressed by its effectiveness. Guaifenesin is in the category of drugs - Generally Recognized as Safe - (GRAS) and is included in many prescription and over-the-counter cough remedies,1 but the manufacturer of Mucinex nevertheless sought and received FDA approval. Now the FDA has removed all single-ingredient extended-release guaifenesin products from the market until the manufacturers also apply for and receive approval. Mucinex is available without a prescription for patients 12 years or older and is taken every 12 hours. A bottle of 20 600-mg tablets costs about $12 at a local chain pharmacy.
1. Over-the-counter (OTC) cough remedies. Med Lett Drugs Ther 2001; 43:23.
1. Over-the-counter (OTC) cough remedies. Med Lett Drugs Ther 2001; 43:23.
Over-the-counter (OTC) Cough Remedies
The Medical Letter on Drugs and Therapeutics • March 19, 2001; (Issue 1100)
The number of cough remedies available in the USA continues to multiply, but most products contain the same or similar ingredients in varying combinations. Most acute coughs do not require treatment with drugs,...
The number of cough remedies available in the USA continues to multiply, but most products contain the same or similar ingredients in varying combinations. Most acute coughs do not require treatment with drugs, especially in children, and suppression of a productive cough may be harmful.